APA (7th ed.) Citation

H, H., SSB, S., S, I., T, A., KA, B., MSR, C., . . . MM, R. (2026). Prime Editing, CRISPR-Cas9, and NanoCas Genome Editing for Cancer Treatment. Molecular biotechnology, 68(6), 2630. https://doi.org/10.1007/s12033-025-01548-9

Chicago Style (17th ed.) Citation

H, Hossain, Sayeed SSB, Islam S, Ahmad T, Brishty KA, Chowdhury MSR, Alam MS, Mahmud MS, and Rahman MM. "Prime Editing, CRISPR-Cas9, and NanoCas Genome Editing for Cancer Treatment." Molecular Biotechnology 68, no. 6 (2026): 2630. https://doi.org/10.1007/s12033-025-01548-9.

MLA (9th ed.) Citation

H, Hossain, et al. "Prime Editing, CRISPR-Cas9, and NanoCas Genome Editing for Cancer Treatment." Molecular Biotechnology, vol. 68, no. 6, 2026, p. 2630, https://doi.org/10.1007/s12033-025-01548-9.